Skip to main content

Advertisement

SpringerLink
Log in

Pharmacists’ Interventions for Optimization of Medication Use in Nursing Homes

A Systematic Review

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

The elderly use more medications than younger adults. In addition, the prevalence of inappropriate prescribing is high in nursing homes. The aim of this review was to collect and interpret the results of clinical studies of interventions involving pharmacists aimed at improving the quality of prescribing in nursing homes, and to identify the key elements for a successful intervention. To this end, we searched MEDLINE, International Pharmaceutical Abstracts and EMBASE from January 1987 to May 2008. Studies were selected that (i) involved a pharmacist; (ii) took place in the nursing home setting; (iii) involved residents aged ≥65 years; (iv) included residents with a range of diseases (not targeted at a specific pathology); (v) were controlled trials (randomized or not). The search strategy retrieved eight controlled studies that fitted the inclusion criteria. A meta-analysis was not possible because of the difference in outcomes chosen in the publications. We found mixed evidence for the effectiveness of various interventions by pharmacists on pharmacotherapy in the nursing home setting. Pharmacists can have different roles in the nursing home such as performing regular medication reviews, being an active member of a multidisciplinary team and/or educating physicians, nurses and other nursing home staff about medication use. Our review shows that the available evidence is mixed concerning the effectiveness of interventions by pharmacists on pharmacotherapy in the nursing home setting. At the same time, greater pharmacist involvement has been shown in published studies to increase physicians’ and nurses’ knowledge and awareness about medication. Evidence is scarce, however, and there is a need for large, well conducted randomized controlled trials in the nursing home setting. Attention should be paid to the choice of outcome measures and to multidisciplinary collaboration when assessing the effects of pharmacists’ interventions on medication use in nursing homes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Table II

Similar content being viewed by others

References

  1. Jones D, Poole C. Medicine taking by elderly people: an overview. In: George CF, Woodhouse KW, editors. Drug therapy in old age. Chichester, UK: Wiley and Sons, 1998: 1–22

    Google Scholar 

  2. Walley T, Scott AK. Prescribing in the elderly. Postgrad Med J 1995; 71(838): 466–71

    PubMed  PubMed Central  CAS  Google Scholar 

  3. Lau DT, Kasper JD, Potter DE, et al. Hospitalisation and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005; 165: 68–74

    PubMed  Google Scholar 

  4. Perri M, Menon AM, Deshpande AD, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005; 39(3): 405–11

    PubMed  Google Scholar 

  5. Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117(8): 684–9

    PubMed  CAS  Google Scholar 

  6. Schmader KE, Hanlon JT, Weinberger M, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994; 42(12): 1241–7

    PubMed  CAS  Google Scholar 

  7. Gupta S, Rappaport HM, Bennett LT. Inappropriate drug prescribing and related outcomes for elderly Medicaid beneficiaries residing in nursing homes. Clin Ther 1996; 18(1): 183–96

    PubMed  CAS  Google Scholar 

  8. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994; 272(4): 292–6

    PubMed  CAS  Google Scholar 

  9. Aparasu RR, Sitzman SJ. Inappropriate prescribing for the elderly in the outpatient department setting. Am J Health-Syst Pharm 1999; 56(5): 433–9

    PubMed  CAS  Google Scholar 

  10. Levenson SA, Saffel DA. The consultant pharmacist and the physician in the nursing home: roles, relationships, and a recipe for success. J Med Dir 2007; 8(1): 55–64

    Google Scholar 

  11. Furniss L, Craig SKL, Burns A. Medication use in nursing homes for elderly people. Int J Geriatr Psychiatr 1998; 13(7): 433–9

    CAS  Google Scholar 

  12. Simonson W, Feinberg JL. Medication-related problems in the elderly: defining the issues and identifying solutions. Drugs Aging 2005; 22(7): 559–69

    PubMed  Google Scholar 

  13. Stoudemire A, Smith DA. OBRA regulations and the use of psychotropic drugs in long-term care facilities: impact and implications for geropsychiatric care. Gen Hosp Psychiatry 1996; 18(2): 77–94

    PubMed  CAS  Google Scholar 

  14. Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc 1990; 38(5): 542–52

    PubMed  CAS  Google Scholar 

  15. Kaldy J. Teacher, teacher: when pharmacists embrace their role as educators. Consult Pharm 2008; 23(2): 100–102, 105-106, 109-10

    PubMed  Google Scholar 

  16. Linnebur SA, O’Connell MB, Wessell AM, et al. Pharmacy practice, research, education, and advocacy for older adults. Pharmacotherapy 2005; 25(10): 1396–430

    PubMed  Google Scholar 

  17. Cameron KA. Preventing medication-related problems among older Americans. Manag Care Interface 1998; 11(10): 74–76, 78, 83-5

    PubMed  CAS  Google Scholar 

  18. Harjivan C, Lyles A. Improved medication use in long-term care: building on the consultant pharmacist’s drug regimen review. Am J Manag Care 2002; 8(4): 318–26

    PubMed  Google Scholar 

  19. Bootman JL, Harrison DL, Cox ER. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997; 157(18): 2089–96

    PubMed  CAS  Google Scholar 

  20. Daschner M, Brownstein S, Cameron KA, et al. Fleetwood phase II tests a new model of long-term care pharmacy. Consult Pharm 2000; 15(10): 989–1005

    Google Scholar 

  21. Christian JB, van Haaren A, Cameron KA, et al. Alternatives for potentially inappropriate medications in the elderly population: treatment algorithms for use in the Fleetwood Phase III study. Consult Pharm 2004; 19(11): 1011–28

    PubMed  Google Scholar 

  22. Lapane KL, Hiris J, Hughes CM, et al. Development and implementation of pharmaceutical care planning software for nursing homes based on the Fleetwood Model. Am J Health Syst Pharm 2006; 63(24): 2483–7

    PubMed  Google Scholar 

  23. Roughead EE, Semple SJ, Gilbert AL. Quality use of medicines in aged-care facilities in Australia. Drugs Aging 2003; 20(9): 643–53

    PubMed  Google Scholar 

  24. Klepping G. Medication review in elderly care homes. Prim Care Pharm 2000; 1(4): 105–8

    Google Scholar 

  25. Schmidt I, Claesson CB, Westerholm B, et al. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 1998; 46(1): 77–82

    PubMed  CAS  Google Scholar 

  26. Schmidt IK, Claesson CB, Westerholm B, et al. Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother 1998; 32(1): 27–32

    PubMed  CAS  Google Scholar 

  27. Furniss L, Burns A, Craig SKL, et al. Effects of a pharmacist’s medication review in nursing homes: randomised controlled trial. Br J Psychiatry 2000; 176: 563–7

    PubMed  CAS  Google Scholar 

  28. Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001; 51(3): 257–65

    PubMed  PubMed Central  CAS  Google Scholar 

  29. Crotty M, Whitehead C, Rowett D, et al. An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial [ISRCTN67855475]. BMC Health Serv Res 2004; 4(1): 6

    PubMed  PubMed Central  Google Scholar 

  30. Crotty M, Halbert J, Rowett D, et al. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 2004; 33(6): 612–7

    PubMed  Google Scholar 

  31. Crotty M, Rowett D, Spurling L, et al. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004; 2(4): 257–64

    PubMed  Google Scholar 

  32. Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes: randomised controlled trial. Age Ageing 2006; 35(6): 586–91

    PubMed  Google Scholar 

  33. King MA, Roberts MS. Multidisciplinary case conference reviews: improving outcomes for nursing home residents, carers and health professionals. Pharm World Sci 2001; 23(2): 41–5

    PubMed  CAS  Google Scholar 

  34. Majumdar SR, Soumerai SB. Why most interventions to improve physician prescribing do not seem to work. Can Med Assoc J 2003; 169(1): 30–1

    Google Scholar 

  35. Handler SM, Wright RM, Ruby CM, et al. Epidemiology of medication-related adverse events in nursing homes. Am J Geriatr Pharmacother 2006; 4(3): 264–72

    PubMed  Google Scholar 

  36. Nester TM, Hale LS. Effectiveness of a pharmacist-acquired medication history in promoting patient safety. Am J Health-Syst Pharm 2002; 59(22): 2221–5

    PubMed  Google Scholar 

  37. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy 2002; 22(2): 134–47

    PubMed  CAS  Google Scholar 

  38. Al-Rashed SA, Wright DJ, Roebuck N, et al. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol 2002; 54(6): 657–64

    PubMed  PubMed Central  CAS  Google Scholar 

  39. Boddy C. Pharmacist involvement with warfarin dosing for inpatients. Pharm World Sci 2001; 23(1): 31–5

    PubMed  CAS  Google Scholar 

  40. Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health-Syst Pharm 2002; 59(21): 2089–92

    PubMed  Google Scholar 

  41. Kucukarslan SN, Peters M, Mlynarek M, et al. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003; 163(17): 2014–8

    PubMed  Google Scholar 

  42. Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy 1999; 19(5): 556–64

    PubMed  CAS  Google Scholar 

  43. Mol PGM, Wieringa JE, NannanPanday PV, et al. Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis. J Antimicrob Chemother 2005; 55(4): 550–7

    PubMed  CAS  Google Scholar 

  44. Schiller DS. Identification, management, and prevention of adverse effects associated with highly active antiretroviral therapy. Am J Health-Syst Pharm 2004; 61(23): 2507–22

    PubMed  Google Scholar 

  45. Krishnan HS, Schaefer M. Evaluation of the impact of pharmacist’s advice giving on the outcomes of self-medication in patients suffering from dyspepsia. Pharm World Sci 2000; 22(3): 102–8

    PubMed  CAS  Google Scholar 

  46. Buurma H, De Smet P, Leufkens HGM, et al. Evaluation of the clinical value of pharmacists’ modifications of prescription errors. Br J Clin Pharmacol 2004; 58(5): 503–11

    PubMed  PubMed Central  Google Scholar 

  47. Hawksworth GM, Corlett AJ, Wright DJ, et al. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 1999; 47(6): 695–700

    PubMed  PubMed Central  CAS  Google Scholar 

  48. Chabot I, Moisan J, Gregoire JP, et al. Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003; 37(9): 1186–93

    PubMed  Google Scholar 

  49. Saini B, Krass I, Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother 2004; 38(11): 1954–60

    PubMed  Google Scholar 

  50. MacLaughlin EJ, MacLaughlin AA, Snella KA, et al. Osteoporosis screening and education in community pharmacies using a team approach. Pharmacotherapy 2005; 25(3): 379–86

    PubMed  Google Scholar 

  51. Jaber LA, Halapy H, Fernet M, et al. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996; 30(3): 238–43

    PubMed  CAS  Google Scholar 

  52. Carter BL, Barnette DJ, Chrischilles E, et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy 1997; 17(6): 1274–85

    PubMed  CAS  Google Scholar 

  53. Erickson SR, Slaughter R, Halapy H. Pharmacists’ ability to influence outcomes of hypertension therapy. Pharmacotherapy 1997; 17(1): 140–7

    PubMed  CAS  Google Scholar 

  54. Solomon DK, Portner TS, Bass GE, et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc 1998; 38(5): 574–85

    CAS  Google Scholar 

  55. Cowper PA, Weinberger M, Hanlon JT, et al. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy 1998; 18(2): 327–32

    PubMed  CAS  Google Scholar 

  56. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Pharmacotherapy 2000; 20(12): 1508–16

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Funding for this review was provided by the Belgian Healthcare Knowledge Center (KCE), within the framework of the PHEBE (Prescribing in Homes for the Elderly in BElgium) study [D/2006/10.273/61]. The authors have no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Harelbekestraat 72, 9000, Ghent, Belgium

    Charlotte L. R. Verrue, Els Mehuys & Jean Paul Remon

  2. Heymans Institute of Pharmacology, Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium

    Mirko Petrovic & Robert Vander Stichele

  3. Department of Geriatrics, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium

    Mirko Petrovic

Authors
  1. Charlotte L. R. Verrue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mirko Petrovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Els Mehuys
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean Paul Remon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert Vander Stichele
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mirko Petrovic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verrue, C.L.R., Petrovic, M., Mehuys, E. et al. Pharmacists’ Interventions for Optimization of Medication Use in Nursing Homes. Drugs Aging 26, 37–49 (2009). https://doi.org/10.2165/0002512-200926010-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/0002512-200926010-00003

Keywords

Search

Navigation